Home Depot Posts Mixed Financial Results
Home Depot (HD) has reported mixed financial results for this year’s calendar first quarter. The Atlanta-based home improvement retailer announced earnings per share (EPS) of $3.56 U.S., which fell short of the $3.60 U.S. expected on Wall Street. However, revenue in the period totaled $39.86 billion U.S., which was ahead of the $39.31 billion U.S. consensus forecast among analysts. Sales were up 9% from a year earlier. Despite the mixed results, management at Home Depot maintained their full-year sales forecast and stressed that they do not plan to raise prices due to import tariffs.More than half of what the company sells comes from within the U.S., said Home Depot executives. And the company plans to decrease the share of purchases that come from abroad. By 2026, no single country outside of the U.S. will represent more than 10% of the company’s purchases. For all of this year, Home Depot expects total sales to grow by 2.8% and comparable sales to rise 1%. As Home Depot grapples with a more challenging housing market, the company has switched its focus to target home professionals and builders rather than homeowners. In 2024, the company acquired SRS Distribution, a Texas-based company that sells supplies to roofing, pool and landscaping professionals. That acquisition cost $18.25 billion U.S.In its fiscal first quarter, transactions across Home Depot’s website and retail stores rose a combined 2.1% year-over-year. The average ticket item amounted to $90.71 U.S., only a few cents above the average seen a year ago.The stock of Home Depot has declined 2% this year to trade at $379.38 U.S. per share.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


